Houston's job market has seen a growing demand for coders, as companies seek to bring coding in house. DigitalCrafts is stepping in to provide an educated workforce. Courtesy of DigitalCrafts

When DigitalCrafts hosted its first coding boot camp in Houston, it opened with eight people. Two years later, the organization's next class will graduate 125 people as coders, ready to take on the challenges of the Bayou City's 21st century work environment.

"We work with local companies as part of our advising board," says Jason Ephraim, the Houston campus director. "And our students go to work for those companies when they complete our program. That kind of localization helps us understand what the Houston ecosystem needs in terms of workforce skills, and allows us to adapt our curriculum to meet their needs, which helps us ensure our graduates get placed."

DigitalCrafts began in Atlanta, co-founded by Max McChesney and Jake Hadden. The Houston outpost is only the second expansion for the company, a move Ephraim says is a deliberate; DigitalCrafts looks to make small, impactful changes as a company, better ensuring it meets the needs of both its students and the workforce they'll enter.

The company offers a project-based curriculum, where outside companies come into the classroom and describe the challenges they're facing. Students are then offered the opportunity to work in teams on digital solutions, providing an experiential learning environment that mirrors what they might find in their careers.

"In Atlanta, we work with companies like the Home Depot and Chick-Fil-A, but here in Houston, where energy is still dominant, we have companies come in and explain the tools they need to maximize their business," Ephraim says. "That means students are working on actual projects with an end result for a business, and it gives them exposure to area businesses."

That combination of providing a deep dive into coding and partnering with Houston companies helps DigitalCrafts graduates get an edge on the competition. The program itself is super hands on, and most of the students who come into it have taken at least one computer programming course, most likely Python or JavaScript, whether in the course of their college education or via a MOOC (massive open online course).

"For most of our students, that exposure wasn't enough and they want a deeper dive," says Ephraim.

DigitalCrafts offers both full- and part-time class options. The full-time program is 16 weeks and fully immersive. Students take courses every day, building on skills and training as full-stack developers. The part-time sessions unfold across 26 weeks, and students learn front- and back-end web development.

"Our goal has always been to help our students be ready for careers in all aspects of software and web development," says Ephraim. "The average student is 30, and looking to either make a career change to coding and development, or wants to enhance what he or she has already learned."

The vetting process for students is exacting, explains Ephraim. Each applicant is evaluated based not only on what he or she knows and is looking to learn, but also in terms of what his or her individual career goals are. DigitalCrafts looks to ensure that its programs will meet the needs of its students.

Ephraim says that given Houston's current job landscape, the need for coders is strong — and growing.

"Over the last two years, we're seeing companies who used to outsource this kind of development bringing it back in-house," he says. "That's created a really high demand for people who understand coding and programming and know how to solve problems. And it's not just happening at energy companies. It's happening in finance, in health care."

In short, the industries that play a huge role in keeping the Houston economy ticking.

In addition to offering its in-depth boot camps, DigitalCrafts also contracts with companies to train employees. The company will either offer basic classes or work with an organization to custom-create a curriculum based on individual needs. Ephraim says that his organization has had success in the Bayou City because it's made it a point to understand the local landscape, as well as look at the larger picture of what digital careers here look like.

"Houston isn't like Austin, where you have that almost stereotypical idea of people walking around with their laptops and working in coffee shops," Ephraim says. "The digital landscape here is different, and there are jobs here for those who know how to fill this need. Companies here want to hire Houstonians. We're here to help make sure they can."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston researchers develop dissolvable implant for targeted cancer drug delivery

cancer research

Researchers at Houston Methodist have developed a biodegradable implant that can be used to safely and consistently deliver drug treatments to tumors and then dissolve without the need for further surgery.

The implant is only the size of a grain of rice, but its potential is staggering. The biodegradable nanofibrous drug-eluting seed (b-NDES) works as a reservoir parked inside a soft tumor, where it can slowly release immune-stimulating drugs over time. This overcomes a consistent problem with drugs such as immune checkpoint inhibitors. Normal systemic administration sees comparatively little of the drug making its way to the tumor, with most of it circulating throughout the body. The b-NDES is like deploying a small guerrilla fighting force embedded in enemy territory, doing maximum damage to the entrenched tumor.

"To improve cancer treatment, we're trying to start a fire inside the tumor itself," Corrine Chua, associate professor in the Center for BioNanoengineering at Houston Methodist Research Institute, said in a news release. "By activating immune cells directly within the tumor microenvironment, those cells can then travel throughout the body and seek out cancer wherever it exists. The b-NDES platform was developed to help keep therapeutic drugs concentrated inside tumors while minimizing exposure to healthy tissues.”

Chua co-led the study with Alessandro Grattoni, chair and director of the Center for BioNanoengineering at Houston Methodist Research Institute.

The study included support from the Nancy Owens Breast Cancer Foundation and the National Institutes of Health/National Cancer Institute.

Chau and Grattoni used preclinical models of triple-negative breast cancer, an aggressive form of cancer that is estrogen receptor-negative, progesterone receptor-negative and HER2-negative. Because of the receptor negativity, some popular treatments like tamoxifen and trastuzumab are ineffective. Chemotherapy has been shown to be the best course of action.

The b-NDES implant is deployed alongside radiation drugs. It keeps the drugs focused on the tumor, reducing the amount of harmful side effects typically seen when drugs are circulated more widely in the body. In 60 percent of the models, tumors were eliminated and did not cause side effects beyond the tumor site. Once the drugs have been deployed, the implant breaks down naturally.

While promising, more research will have to be done to expand use to other tumor types.

"Although the study focused on triple-negative breast cancer models, the approach could have broader applications for solid tumors," Grattoni added in the release. "It could potentially be used in cancers where there is a tumor lesion accessible for placement, including pancreatic or lung cancers."

New Houston platform Same Day Reels launches for on-demand content creation

In The Moment

If an event doesn't happen on Instagram, did it even really happen? In today's social media-driven age of branding and audience engagement, the answer increasingly is no.

Houston entrepreneur Karen De Amat is looking to fill the online content creation needs of companies with her new venture, Same Day Reels, which launched in early August. It will serve as a platform to connect companies and brands with talent that can help turn an event into a viral moment as it is happening.

"Events move quickly, and social media moves even faster,” said De Amat. “Same Day Reels was built to help brands capture the moment while it still matters. We are creating a more efficient way for businesses and creators to work together. Brands need content faster, and creators need more opportunities to turn their talent into real work. Same Day Reels brings those needs together.”

The company is focused on adding livestreams and concurrent short video content to "activations, launches, fundraisers, grand openings, conferences, hospitality experiences, and private celebrations." Such content can significantly increase the visibility of a product or brand according to digital marketing brands like Wyzowl, whose data found 63 percent of people in 2026 prefer to learn about new products via short video.

Packages offered by Same Day Reels will include filming, editing, and publishing content within hours of the targeted event.

De Amat says that her content creation platform will be a way to preserve the excitement of events and launches by enshrining them with immediate social media-driven memories.

“Event content is no longer just something you post after the fact,” De Amat said. “It is part of how people experience, remember and share the moment.”

Previously, De Amat is also the founder and CEO of Social Behavior, an influencer marketing company she launched from her home in 2014. It quickly garnered an array of clients and thrust De Amat into the spotlight, including numerous appearances on Fox 26's The Isiah Factor. Influencer Marketing Hub named her one of the top CEOs of influencer marketing companies in Houston in 2025.

---

This article originally appeared on CultureMap.com.

Bristol Myers Squibb to build $2.3B Houston pharma manufacturing campus

coming soon

New Jersey-based pharmaceutical giant Bristol Myers Squibb Co. has officially named Houston as the home of its new state-of-the-art manufacturing site.

The 60,000-square-foot facility represents a $2.3 billion investment, according to a news release. It is expected to create 500 skilled jobs and will be located in Houston's Generation Park.

BMS first announced that it was considering Houston among 16 other cities for the facility in May. The new hub will manufacture small molecule, biologic and antibody-drug conjugates and is part of a $40 billion commitment to invest in the United States over five years. Construction is slated to begin next year, with the facility coming online in 2030.

"We're building the domestic manufacturing capabilities needed to deliver the next generation of medicines and support future scientific breakthroughs. Houston and the state of Texas offer the talent, infrastructure, and partnership needed to help bring that vision to life," Christopher Boerner, CEO and board chair of BMS, said in the release.

The new facility will feature a modular, multi-modal design, which will allow the company to reconfigure and add to its manufacturing capabilities over time. BMS says it expects the facility to "(grow) in scale and capability well beyond its opening configuration."

"Our decision to build this state-of-the-art manufacturing campus in Houston, Texas, reflects our confidence in the region’s ability to support a world-class, digitally advanced supply operation,” Karin Shanahan, EVP and chief supply chain and operations officer of BMS, added in the release. “This facility is designed to deliver the speed, quality, and reliability that patients depend on, combining flexible, modular manufacturing with advanced digital capabilities to ensure consistent supply across multiple modalities. It strengthens our ability to operate with resilience and positions us to reliably deliver medicines to patients today while adapting future demands.”

Texas Gov. Greg Abbott shared that the state has granted BMS a $4.89 million Texas Enterprise Fund (TEF) grant for the project. TEF grants, administered by the Texas Economic Development & Tourism Office, support business relocation or expansion projects that create "new, good-paying jobs in the community and attract significant new capital investment to the state." The development is also a qualified project under the Texas Jobs, Energy, Technology, and Innovation (JETI) program.

“Texas is a global hub for life sciences, where today’s innovations shape the future of healthcare,” Abbott said in a news release. “This $2.3 billion investment by Bristol Myers Squibb in the dynamic biotech ecosystem in Houston is a testament to the depth of our skilled workforce and the pipeline of talent coming through our nation-leading technical colleges and research universities. With lower operating costs and easy access to markets across the U.S. and the world, Texas drives affordability for consumers.”

"Bristol Myers Squibb’s announcement is a tremendous win for Texas and the Houston region, further reinforcing our position as a premier destination for life sciences and advanced manufacturing,” added Greater Houston Partnership President and CEO Steve Kean.

Last fall, Eli Lilly and Co. selected Generation Park, a 4,300-acre, master-planned commercial district near Lake Houston, for its $6.5 billion manufacturing plant. More than 300 locations in the U.S. competed for the factory. Read more here.